BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37697216)

  • 1. Absence of anti-rabphilin-3A antibodies in children and young adults with idiopathic central diabetes insipidus: a potential clue to elucidating a tumor etiology.
    Fujisawa H; Takeuchi T; Ishii A; Muto J; Kamasaki H; Suzuki A; Sugimura Y
    Hormones (Athens); 2023 Dec; 22(4):747-758. PubMed ID: 37697216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on anti-rabphilin-3A antibodies in 15 consecutive patients presenting with central diabetes insipidus at a single referral center.
    Arihara Z; Sakurai K; Niitsuma S; Sato R; Yamada S; Inoshita N; Iwata N; Fujisawa H; Watanabe T; Suzuki A; Takahashi K; Sugimura Y
    Sci Rep; 2022 Mar; 12(1):4440. PubMed ID: 35292721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune diabetes insipidus.
    Scherbaum WA
    Handb Clin Neurol; 2021; 181():193-204. PubMed ID: 34238458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 7-year-old boy with central diabetes insipidus presenting with thickened pituitary stalk and anti-rabphilin-3A antibody positivity.
    Morota K; Tadokoro H; Sawano K; Watanabe K; Iwata N; Fujisawa H; Suzuki A; Sugimura Y; Nagasaki K
    J Pediatr Endocrinol Metab; 2022 May; 35(5):687-690. PubMed ID: 35119230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocytic infundibuloneurohypophysitis with positive anti-rabphilin-3A antibodies nine years post-onset of central diabetes insipidus.
    Kume Y; Sakuma H; Sekine H; Sumikoshi M; Sugimura Y; Hosoya M
    Clin Pediatr Endocrinol; 2021; 30(1):65-69. PubMed ID: 33446956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic central diabetes insipidus in children and young adults is commonly associated with vasopressin-cell antibodies and markers of autoimmunity.
    Maghnie M; Ghirardello S; De Bellis A; di Iorgi N; Ambrosini L; Secco A; De Amici M; Tinelli C; Bellastella A; Lorini R
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):470-8. PubMed ID: 16984239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rabphilin-3A as a Targeted Autoantigen in Lymphocytic Infundibulo-neurohypophysitis.
    Iwama S; Sugimura Y; Kiyota A; Kato T; Enomoto A; Suzuki H; Iwata N; Takeuchi S; Nakashima K; Takagi H; Izumida H; Ochiai H; Fujisawa H; Suga H; Arima H; Shimoyama Y; Takahashi M; Nishioka H; Ishikawa SE; Shimatsu A; Caturegli P; Oiso Y
    J Clin Endocrinol Metab; 2015 Jul; 100(7):E946-54. PubMed ID: 25919460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of anti-rabphilin-3A antibodies for diagnosing central diabetes insipidus in the third trimester of pregnancy.
    Sakurai K; Yamashita R; Niituma S; Iwama S; Sugimura Y; Arihara Z; Takahashi K
    Endocr J; 2017 Jun; 64(6):645-650. PubMed ID: 28420857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation and outcome of children with central diabetes insipidus associated with a self-limited or transient pituitary stalk thickening, diagnosed as infundibuloneurohypophysitis.
    Schaefers J; Cools M; De Waele K; Gies I; Beauloye V; Lysy P; Francois I; Beckers D; De Schepper J
    Clin Endocrinol (Oxf); 2017 Aug; 87(2):171-176. PubMed ID: 28444954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocytic Infundibuloneurohypophysitis Diagnosis Owing to Positive Anti-rabphilin-3A Antibody Test Result in an 8-year-old Boy with Early-onset Central Diabetes İnsipidus.
    Shoji Y; Naruse Y; Iwata N; Fujisawa H; Suzuki A; Sugimura Y; Mori M; Hiramoto R
    J Clin Res Pediatr Endocrinol; 2023 Sep; ():. PubMed ID: 37743662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central diabetes insipidus with anti-rabphilin-3A antibody positivity causing hypovolemic shock after resection of tumorous lesions in the pelvic cavity.
    Ohashi A; Takeda Y; Watada M; Ihara F; Oshita T; Iwata N; Fujisawa H; Suzuki A; Sugimura Y; Maeda Y
    CEN Case Rep; 2023 Aug; 12(3):297-303. PubMed ID: 36574196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central diabetes insipidus: Is it Langerhans cell histiocytosis of the pituitary stalk? A diagnostic pitfall.
    Prosch H; Grois N; Bökkerink J; Prayer D; Leuschner I; Minkov M; Gadner H
    Pediatr Blood Cancer; 2006 Mar; 46(3):363-6. PubMed ID: 15942956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thickening of the pituitary stalk in children and adolescents with central diabetes insipidus: Causes and consequences].
    Corredor Andrés B; Muñoz Calvo MT; López Pino MÁ; Márquez Rivera M; Travieso Suárez L; Pozo Román J; Argente J
    An Pediatr (Engl Ed); 2019 May; 90(5):293-300. PubMed ID: 29895434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the etiological and clinical characteristics of pediatric central diabetes insipidus.
    Gasimova E; Berberoğlu M; Özsu E; Aycan Z; Uyanık R; Bilici E; Ceran A; Şiklar Z
    J Pediatr Endocrinol Metab; 2022 Aug; 35(8):1089-1096. PubMed ID: 35822703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric Central Diabetes Insipidus: Brain Malformations Are Common and Few Patients Have Idiopathic Disease.
    Werny D; Elfers C; Perez FA; Pihoker C; Roth CL
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3074-80. PubMed ID: 26030323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary Stalk Thickening: Causes and Consequences. The Children's Memorial Health Institute Experience and Literature Review.
    Moszczyńska E; Kunecka K; Baszyńska-Wilk M; Perek-Polnik M; Majak D; Grajkowska W
    Front Endocrinol (Lausanne); 2022; 13():868558. PubMed ID: 35669693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal study of vasopressin-cell antibodies and of hypothalamic-pituitary region on magnetic resonance imaging in patients with autoimmune and idiopathic complete central diabetes insipidus.
    De Bellis A; Colao A; Bizzarro A; Di Salle F; Coronella C; Solimeno S; Vetrano A; Pivonello R; Pisano G; Lombardi G; Bellastella A
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3825-9. PubMed ID: 12161517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central diabetes insipidus and pituitary stalk thickening in adults: distinction of neoplastic from non-neoplastic lesions.
    Devuyst F; Kazakou P; Balériaux D; Alexopoulou O; Burniat A; Salenave S; Chanson P; Corvilain B; Maiter D
    Eur J Endocrinol; 2020 Jul; 181(3):95-105. PubMed ID: 32530258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central diabetes insipidus and autoimmunity: relationship between the occurrence of antibodies to arginine vasopressin-secreting cells and clinical, immunological, and radiological features in a large cohort of patients with central diabetes insipidus of known and unknown etiology.
    Pivonello R; De Bellis A; Faggiano A; Di Salle F; Petretta M; Di Somma C; Perrino S; Altucci P; Bizzarro A; Bellastella A; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1629-36. PubMed ID: 12679449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic hypothalamic diabetes insipidus, pituitary stalk thickening, and the occult intracranial germinoma in children and adolescents.
    Mootha SL; Barkovich AJ; Grumbach MM; Edwards MS; Gitelman SE; Kaplan SL; Conte FA
    J Clin Endocrinol Metab; 1997 May; 82(5):1362-7. PubMed ID: 9141516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.